Canada Life
PETX

Canada Life’s Aratana Therapeutics, Inc. PETX Stock Holding History

Canada Life’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,501
Closed -$30K – 2473
2015
Q3 		$30K Hold
3,501
– – ﹤0.01% 2255
2015
Q2 		$53K Hold
3,501
– – ﹤0.01% 2187
2015
Q1 		$56K Buy
+3,501
New +$62.3K ﹤0.01% 2081

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Canada Life's PETX Position: Q4 2015 in Review

Canada Life sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 3,501 shares — an estimated $30K sold.

Canada Life first reported a position in PETX in Q1 2015 and held it in 3 quarters. The position peaked at $56K in Q1 2015. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

  • Canada Life reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Canada Life sold 3,501 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $30K.
  • Canada Life first reported a position in Aratana Therapeutics, Inc. in Q1 2015 and held it in 3 quarters.
  • Canada Life's Aratana Therapeutics, Inc. position peaked at $56K in Q1 2015.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on Canada Life's 13F filing for Q4 2015, filed 29 Jan 2016.